UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAFV600E glioblastoma results in sustained response: A case report

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae110

2024

Volltextzugriff (PDF)

Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma

Clinical cancer research, 2024-01, Vol.30 (2), p.323-333

2024

Volltextzugriff (PDF)

Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors

CNS oncology, 2019-06, Vol.8 (2), p.CNS34

2019

Volltextzugriff (PDF)

Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases

Cancer cell international, 2014-03, Vol.14 (1), p.26-26, Article 26

2014

Volltextzugriff (PDF)

Activity of pemetrexed in pre-clinical chordoma models and humans

Scientific reports, 2023-05, Vol.13 (1), p.7317-7317, Article 7317

2023

Volltextzugriff (PDF)

Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer

Neuro-oncology advances, 2021-01, Vol.3 (1), p.vdab006-vdab006

2021

Volltextzugriff (PDF)

Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds

Biomaterials, 2001-06, Vol.22 (11), p.1279-1288

2001

Volltextzugriff (PDF)

A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae049-vdae049

2024

Volltextzugriff (PDF)

Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001

International medical case reports journal, 2022-01, Vol.15, p.735-738

2022

Volltextzugriff (PDF)

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

European journal of immunology, 2004-04, Vol.34 (4), p.961-971

2004

Volltextzugriff (PDF)

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

Translational medicine communications, 2021-08, Vol.6 (1), p.1-19, Article 19

2021

Volltextzugriff (PDF)

Mesenchymal stem cells in the treatment of severe COVID-19

Translational medicine communications, 2021-08, Vol.6 (1), p.1-16, Article 16

2021

Volltextzugriff (PDF)

ACTR-56. PHASE II TRIAL OF NILOTINIB IN PDGFR-ALPHA ENRICHED RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi26-vi26

2019

Volltextzugriff (PDF)

QLTI-09. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK: UPDATED INFO AFTER 17 MONTHS OF UTILIZATION

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v246-v247

2023

Volltextzugriff (PDF)

Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2057-2057

2023

Volltextzugriff (PDF)

NCOG-33. GLIOBLASTOMA AND PARKINSONISM, IS DEPLETED DOPAMINE A PROTECTIVE SURVIVAL FACTOR? A CASE SERIES OF 3 GBM PATIENTS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v221-v221

2023

Volltextzugriff (PDF)

QLTI-26. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii240-vii240

2022

Volltextzugriff (PDF)

EOLP-07. A REAL-WORLD INTEGRATED OUTPATIENT PALLIATIVE AND SUPPORTIVE CARE CLINIC IN A REGIONAL COMMUNITY NEURO-ONCOLOGY PRACTICE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v114-v114

2023

Volltextzugriff (PDF)

QOL-28. THE LIVED EXPERIENCE OF PATIENTS WITH CHORDOMA – A RETROSPECTIVE CASE SERIES

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v255-v255

2023

Volltextzugriff (PDF)

DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi76-vi76

2021

Volltextzugriff (PDF)

QLTI-22. IMPROVING BRAIN CANCER PATIENT ACCESS TO CLINICAL TRIALS ACROSS SEVEN COMMUNITY HOSPITALS, THE PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii239-vii239

2022

Volltextzugriff (PDF)

CTNI-15. PILOT STUDY OF HIGH-DOSE PEMETREXED FOR PROGRESSIVE CHORDOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v76-v76

2023

Volltextzugriff (PDF)

MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi140-vi140

2019

Volltextzugriff (PDF)

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAF V600E glioblastoma results in sustained response: A case report

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae110

2024

Volltextzugriff (PDF)

CSF pharmacokinetics of high-dose pulsatile tyrosine kinase therapy in brain cancer patients

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e13032-e13032

2015

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(11)
Oncology
(11)
Animals
(6)
Glioblastoma
(6)
Brain Cancer
(5)
Patients
(5)
Adult
(4)
Cancer
(4)
Female
(4)
General & Internal Medicine
(4)
Male
(4)
Mice
(4)
Mutation
(4)
Neurosciences & Neurology
(4)
Tumors
(4)
Abstracts
(3)
Abstracts From The 20th Annual Scientific Meeting Of The Society For Neuro-Oncology
(3)
Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAFV600E glioblastoma results in sustained response: A case report

Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma

Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors

Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases

Activity of pemetrexed in pre-clinical chordoma models and humans

Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer

Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds

A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer

Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

Mesenchymal stem cells in the treatment of severe COVID-19

ACTR-56. PHASE II TRIAL OF NILOTINIB IN PDGFR-ALPHA ENRICHED RECURRENT GLIOBLASTOMA

QLTI-09. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK: UPDATED INFO AFTER 17 MONTHS OF UTILIZATION

Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm

NCOG-33. GLIOBLASTOMA AND PARKINSONISM, IS DEPLETED DOPAMINE A PROTECTIVE SURVIVAL FACTOR? A CASE SERIES OF 3 GBM PATIENTS

QLTI-26. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

EOLP-07. A REAL-WORLD INTEGRATED OUTPATIENT PALLIATIVE AND SUPPORTIVE CARE CLINIC IN A REGIONAL COMMUNITY NEURO-ONCOLOGY PRACTICE

QOL-28. THE LIVED EXPERIENCE OF PATIENTS WITH CHORDOMA – A RETROSPECTIVE CASE SERIES

DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

QLTI-22. IMPROVING BRAIN CANCER PATIENT ACCESS TO CLINICAL TRIALS ACROSS SEVEN COMMUNITY HOSPITALS, THE PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

CTNI-15. PILOT STUDY OF HIGH-DOSE PEMETREXED FOR PROGRESSIVE CHORDOMA

MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAF V600E glioblastoma results in sustained response: A case report

CSF pharmacokinetics of high-dose pulsatile tyrosine kinase therapy in brain cancer patients

Suchergebnisse filtern